First Iluvien orders shipped to U.K.

|By:, SA News Editor

Alimera Sciences (ALIM +13.5%) says it has begun shipping the first orders of Iluvien to U.K. NHS facilities.

The company also says "the first NHS patient received an implant for the treatment of DME" on January 10.

For reference: NICE guidance allows for patients with a pseudophakic eye to receive Iluvien when their chronic DME is "considered insufficiently responsive to available therapies." (PR)